JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Designing Hypothesis of 2-Substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl)phenyl] Acetamide Analogs as Anticancer Agents: QSAR Approach
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Designing Hypothesis of 2-Substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl)phenyl] Acetamide Analogs as Anticancer Agents: QSAR Approach
Bedadurge, Ajay B.; Shaikh, Anwar R.;
  PDF(new window)
 Abstract
Quantitative structure-activity relationship (QSAR) analysis for recently synthesized imidazole-(benz)azole and imidazole - piperazine derivatives was studied for their anticancer activities against breast (MCF-7) cell lines. The statistically significant 2D-QSAR models ($r^2
 Keywords
Imidazole-(benz)azole and imidazole-piperazine;Breast (MCF-7) cell line;Anticancer;Quantitative structure-activity relationship;kNN-MFA;
 Language
English
 Cited by
 References
1.
Krikas, G.; Schulpis, K.; Reclos, G.; Kokotos, G. Clin. Biochem. 1998, 31, 405. crossref(new window)

2.
Waring, M.; Bailly, C. Gene 1994, 149, 69. crossref(new window)

3.
Rehn, C.; Pindur, U. Monatsh. Chem. 1996, 127, 631. crossref(new window)

4.
Baginski, M.; Fogolari, F.; Briggs, J. J. Mol. Biol. 1997, 274, 253. crossref(new window)

5.
Shui, X.; et al. Curr. Med. Chem. 2000, 7, 59. crossref(new window)

6.
Neidle, S. In Cancer Drug Desing and Discovery, 2nd Ed.; Elsevier Inc.: U.S.A., 2008, p 132.

7.
Moore, M.; Hunter, W.; Langlis-D'Estaintot, B.; Kennard, O. J. Mol. Bio. 1989, 206, 693. crossref(new window)

8.
Pindur, U.; Haber, M.; Sattler, K. J. Chem. Educ. 1993, 70, 263. crossref(new window)

9.
Zhigang, L.; Qing, Y.; Xuhong, Q. Bioorg. Med. Chem. Lett. 2005, 15, 3143. crossref(new window)

10.
Claiborne, C.; Liverton, N.; Nguyen, K. Tetrahedron Lett. 1998, 39, 8939. crossref(new window)

11.
Cui, B.; Zheng, B.; He, K.; Zheng, Q. J. Nat. Prod. 2003, 66, 1101. crossref(new window)

12.
Fazeny-Dorner, B.; Veitl, M.; Wenzel, C.; Piribauer, M.; Rossler, K.; Dieckmann, K.; Ungersbock, K.; Marosi, C. Anticancer Drugs. 2003, 14, 437. crossref(new window)

13.
Haluska, P.; Dy, G.; A. Adjei, A. Eur. J. cancer. 2008, 38, 1685.

14.
Kotteas, E.; Alamara, C.; Kiagia, M.; Pantazopoulos, K.; Oufas, A.; Provata, A.; Chapidou, A.; Syrigos, K. N. Anticancer Res. 2008, 28, 529.

15.
Perez-ruixo, J.; Piotrovskij, V.; Zhang, S.; Hayes, S.; DePorre, P.; Zannikos, P. Br. J. Clin, Pharmacol. 2006, 62, 81. crossref(new window)

16.
Krezel, I. Farmaco 1998, 53, 342. crossref(new window)

17.
Kumar, D.; Jacob, M. R.; Reynolds, M. B.; Kerwin, S. M. Bioorg. Med. Chem. 2002, 10, 3997. crossref(new window)

18.
Hose, C.; Hollingshead M.; Sausville E.; Monks A.; Mol. Cancer Ther. 2003, 2, 1265.

19.
Al-Masoudi, A.; Al-Soud, Y.; Al-Salihi, N.; Al-Masoudi, N. Chem. Hetetrocycl. Compd. 2006, 42, 1377. crossref(new window)

20.
Jackman, A.; Kimbell, R.; Aherne, G.; Brunton, L.; Jansen, G.; Stephens, T.; Smith, M.; Wardleworth, J.; Boyle, F. Clin. Cancer Res. 1997, 3, 911.

21.
Nelson, J.; Rose, L.; Benneft, L. Cancer Res. 1977, 37, 182.

22.
Martin, B.; Mann, J.; Sageot, A. J. Chem. Soc. Perkin Trans. 1, 1999, 2455.

23.
Brian, B.; Andrew, M.; Hana, K.; Padmakumari, T.; William, P.; Jack, C. Mol. Pharmacol. 1997, 52, 839. crossref(new window)

24.
Hansch, C.; Kurup, A.; Garg, R.; Gao, H. Chem. Rev. 2001, 101, 619. crossref(new window)

25.
Yusuf, O.; Ilhan, I.; Zerrin, I.; Gulsen, A. Eur. J. Med. Chem. 2010, 45, 3320. crossref(new window)

26.
Golbraikh, A.; Tropsha, A. J. Comput. Aided Mol. Des. 2002, 16, 357. crossref(new window)

27.
VLifeMDS 4.2; Molecular Design Suite; Vlife Sciences Technologies Pvt. Ltd.: Pune, India, 2012. www.vlifesciences.com

28.
Gasteiger, J; Marsili, M. Tetrahedron. 1980, 36, 3219. crossref(new window)

29.
Ajmani, S.; Jhadav, K.; Kulkarni, S. A. J. Chem. Inf. Model. 2006, 46, 24. crossref(new window)